A Study to Learn the Effects of Ervogastat (DGAT2i) Given Alone or Together with Clesacostat (ACCi), Compared to Placebo, in People With Non-alcoholic Steatohepatitis and Stage 2 or 3 Fibrosis

A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Dose-Ranging, Dose-Finding, Parallel Group Study to Assess Efficacy and Safety of PF-06865571 (DGAT2i) Alone and When Co-administered With PF-05221304 (ACCi) in Adult Participants With Biopsy-Confirmed Non-alcoholic Steatohepatitis and Fibrosis Stage 2 or 3